jain.com

Series F Convertible Preferred Stock conversion authorization

Company: Applied Digital

This claim was marked delayed on September 4, 2026. Recorded automatically from the cited source when it was published, then queued for evidence review.

How this was decided: Automated extraction from the cited source. The claim is preserved below exactly as it was originally published, so the record shows what was asserted as well as what became of it.

Subject kind
financing
Statement date
2024-10-22
Promised by
2024-11-20
Current status
delayed

The claim, verbatim

Company seeking approval for issuance of common stock upon conversion of Series F Convertible Preferred Stock per Nasdaq Rule 5635

Source (primary)

Applied Digital DEF 14A filed 2024-10-23 (SEC EDGAR, sec_filing)
View cached copy (2026-08-31)Live source ↗

Quote: “To approve, for the purpose of complying with the applicable provisions of The Nasdaq Stock Market LLC ("Nasdaq") Listing Rule 5635, the potential issuance of shares of our common stock issuable upon conversion of our Series F Convertible Preferred Stock”

How we checked this

This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.

Additional evidence

confirms Applied Digital DEF 14A filed 2024-10-23

Quote: “To approve, for the purpose of complying with the applicable provisions of The Nasdaq Stock Market LLC ("Nasdaq") Listing Rule 5635, the potential issuance of shares of our common stock issuable upon conversion of our Series F Convertible Preferred Stock”

View cached copy (2026-08-31)Live source ↗

Record of changes

September 3, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
September 4, 2026 — delayed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.